The Impact of User-Generated Content, Social Interactions and virtual Economies on Metaverse Environments
Journal of Sustainable Economics · 2023
DOI: 10.32734/jse.v1i2.13798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Sustainable Economics, 2023. Verfasst von Zahid Hussain und 2 weiteren Autor:innen. Die Arbeit wurde bisher 25-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
This study examines how user-generated content, social interactions, and virtual economies impact the Metaverse's changing environment. It offers crucial knowledge for policymakers, stakeholders, and developers of the Metaverse in building interesting and long-lasting virtual worlds. The study surveyed 385 respondents from the South Asian demographic using a Likert rating scale through an online survey. Demographic variables were analyzed using SPSS version 29, focusing on frequency and percentage distribution. Means and standard deviations were calculated for each variable and survey item. The main analysis included multiple regression to evaluate hypotheses regarding the interaction between user-generated content, social interaction, and the virtual economy. User-generated content significantly improves Metaverse environments (= 0.22, p
Zitieren
APA
Hussain, Z., Khan, A., & Ali, A. (2023). The Impact of User-Generated Content, Social Interactions and virtual Economies on Metaverse Environments. Journal of Sustainable Economics. https://doi.org/10.32734/jse.v1i2.13798
Vancouver
Hussain Z, Khan A, Ali A. The Impact of User-Generated Content, Social Interactions and virtual Economies on Metaverse Environments. Journal of Sustainable Economics. 2023. doi:10.32734/jse.v1i2.13798
BibTeX
@article{Hussain2023,
author = {Hussain, Zahid and Khan, Arman and Ali, Aftab},
title = {The Impact of User-Generated Content, Social Interactions and virtual Economies on Metaverse Environments},
journal = {Journal of Sustainable Economics},
year = {2023},
doi = {10.32734/jse.v1i2.13798}
}
EUVIMED